Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 5.46% is 16% below its 5-year average of 6.51%, near the low end of its 5-year range (3.18%–21.76%).
As of the fiscal period ended Tuesday, June 30, 2026. 16.33% below its 12-month average of 6.53%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.46%.
DEBT TO ASSETS RATIO
5.46%
DEBT TO ASSETS RATIO AVG TTM
6.53%
DEBT TO ASSETS RATIO AVG 3Y
6.41%
DEBT TO ASSETS RATIO AVG 5Y
6.51%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-16.33%
CURRENT VS 3Y AVG
-14.75%
CURRENT VS 5Y AVG
-16.08%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+5970.43%
vs the sector median at left
Surrozen, Inc.
Market Cap
$198.79M
Debt to Assets Ratio
5.46%
TTM Avg
6.53%
3Y Avg
6.41%
5Y Avg
6.51%
Market Cap
$203.03M
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$204.66M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$205.97M
Debt to Assets Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$191.49M
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$206.79M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Surrozen, Inc. (SRZN) | $198.79M | 5.46% | 6.53% | 6.41% | 6.51% |
| Exagen Inc. (XGN)vs › | $200.72M | 0.49% | N/A | N/A | N/A |
| Alector, Inc. (ALEC)vs › | $195.50M | 0.16% | N/A | N/A | N/A |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $203.03M | 0.20% | N/A | N/A | N/A |
| Whitehawk Therapeutics Inc (WHWK)vs › | $204.66M | 0.00% | N/A | N/A | N/A |
| Electra Therapeutics Inc. (ETRA)vs › | $205.97M | N/A | N/A | N/A | N/A |
| Zentalis Pharmaceuticals, Inc. (ZNTL)vs › | $191.49M | 0.18% | N/A | N/A | N/A |
| RxSight, Inc. (RXST)vs › | $191.22M | 0.03% | N/A | N/A | N/A |
| Sionna Therapeutics, Inc. (SION)vs › | $206.79M | 0.03% | N/A | N/A | N/A |
| Pro-Dex, Inc. (PDEX)vs › | $207.97M | 0.24% | N/A | N/A | N/A |
Debt/Assets
5.5%
Debt/Equity
N/A
Current Ratio
12.14
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 5.46% |
| 2026-03-31 | 5.62% |
| 2025-12-31 | 6.72% |
| 2025-09-30 | 7.53% |
| 2025-06-30 | 7.32% |
| 2025-03-31 | 6.94% |
| 2024-12-31 | 17.47% |
| 2024-09-30 | 3.18% |
| 2024-06-30 | 4.81% |
| 2024-03-31 | 7.59% |
| 2023-12-31 | 7.33% |
| 2023-09-30 | 7.34% |
| 2023-06-30 | 7.08% |
| 2023-03-31 | 6.84% |
| 2022-12-31 | 6.26% |
| 2022-09-30 | 6.69% |
| 2022-06-30 | 6.36% |
| 2022-03-31 | 6.13% |
| 2021-12-31 | 5.68% |
| 2021-09-30 | 5.49% |
| 2021-06-30 | 21.76% |
| 2021-03-31 | 17.66% |
| 2020-12-31 | 15.46% |
